Suppr超能文献

术前淋巴闪烁造影对临床淋巴结阴性皮肤黑色素瘤患者前哨淋巴结状态的预测作用

Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma.

作者信息

Solari Nicola, Gipponi Marco, Stella Mattia, Queirolo Paola, di Somma Carmine, Villa Giuseppe, Piccardo Arnoldo, Gualco Marina, Cardinale Francesco, Cafiero Ferdinando

机构信息

Division of Surgical Oncology, National Cancer Research Institute of Genova, L. go R. Benzi, 10, Genova 16132, Italy.

出版信息

Melanoma Res. 2009 Aug;19(4):243-51. doi: 10.1097/CMR.0b013e32832e0b9a.

Abstract

We reviewed our experience to assess the predictive role of preoperative lymphoscintigraphy with regard to the pathological status of sentinel lymph node (sN) in patients with cutaneous melanoma, to optimize the surgical treatment planning with regard to the use of intraoperative frozen section examination of sN. Eighty-eight patients with clinically node-negative cutaneous melanoma pT1b-T4 stage underwent preoperative lymphoscintigraphy for the lymphatic mapping of sN. A lymphoscintigraphic 'score' (from L1 to L5) was developed based on the ratio of radiotracer concentration within sN nodes as compared with the injection site. Our score allowed us to foresee that sN of patients with thick melanomas (T3 and T4) and a low preoperative score (L1-L2-L3) had a 90% expected likelihood (P<0.001) of harboring metastasis, whereas sN in patients with thin melanomas (T1b-T2) and high preoperative score (from L4 to L5) showed a 100% likelihood of being metastasis free. In conclusion, the sN is a reliable predictor of regional lymph node status in patients with cutaneous malignant melanoma. Moreover, we suggest that a low score (L1-L2-L3) associated with a thick melanoma is a good predictive factor of the positive sN involvement. This information could be useful in scheduling the intraoperative frozen-section examination with an expected benefit of a positive test in almost 90% of patients. Such patients might be selected for a 'one-stage' procedure with a more effective cost/benefit ratio and decreased hospitalization costs.

摘要

我们回顾了自身经验,以评估术前淋巴闪烁显像对皮肤黑色素瘤患者前哨淋巴结(sN)病理状态的预测作用,从而优化关于术中前哨淋巴结冰冻切片检查应用的手术治疗方案。88例临床淋巴结阴性的pT1b - T4期皮肤黑色素瘤患者接受了术前淋巴闪烁显像以进行前哨淋巴结的淋巴图谱绘制。基于前哨淋巴结内放射性示踪剂浓度与注射部位浓度的比值制定了一个淋巴闪烁显像“评分”(从L1到L5)。我们的评分使我们能够预见,厚黑色素瘤(T3和T4)且术前评分低(L1 - L2 - L3)的患者前哨淋巴结发生转移的预期可能性为90%(P<0.001),而薄黑色素瘤(T1b - T2)且术前评分高(从L4到L5)的患者前哨淋巴结无转移的可能性为100%。总之,前哨淋巴结是皮肤恶性黑色素瘤患者区域淋巴结状态的可靠预测指标。此外,我们认为厚黑色素瘤伴有低评分(L1 - L2 - L3)是前哨淋巴结阳性受累的良好预测因素。该信息有助于安排术中冰冻切片检查,预计几乎90%的患者检查结果为阳性。这类患者可选择“一期”手术,具有更有效的成本效益比并降低住院费用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验